Chi‐Ming Lee

521 total citations
11 papers, 450 citations indexed

About

Chi‐Ming Lee is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Chi‐Ming Lee has authored 11 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Pharmacology. Recurrent topics in Chi‐Ming Lee's work include Neuropeptides and Animal Physiology (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Receptor Mechanisms and Signaling (2 papers). Chi‐Ming Lee is often cited by papers focused on Neuropeptides and Animal Physiology (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Receptor Mechanisms and Signaling (2 papers). Chi‐Ming Lee collaborates with scholars based in United Kingdom, United States and Hong Kong. Chi‐Ming Lee's co-authors include Leslie L. Iversen, Bengt Sandberg, Michael R. Hanley, David G. Witte, Tak Ming Wong, Jian‐Zhong Sheng, Hui Dong, Wenlong Huang, Henry Ν. C. Wong and Po‐Ming Hon and has published in prestigious journals such as Journal of Neurochemistry, European Journal of Biochemistry and British Journal of Pharmacology.

In The Last Decade

Chi‐Ming Lee

11 papers receiving 432 citations

Peers

Chi‐Ming Lee

CMN

ONCOL

PHYSI

Cornelis H. Langeveld Netherlands

Guangchun Sun China

W. Saul United States

Seong-Geun Hong South Korea

Toshiaki Akira Japan

Ranju Kumari India

Kayoko Moroi Japan

David Crottès France

Tiesong Shang United States

M. P. Russell United States

Cornelis H. Langeveld Netherlands

Chi‐Ming Lee

246 ×0.9

178 ×0.8

CMN

57 ×0.7

ONCOL

80 ×1.0

PHYSI

29 ×0.6

Citations per year, relative to Chi‐Ming Lee Chi‐Ming Lee (= 1×) peers Cornelis H. Langeveld

Countries citing papers authored by Chi‐Ming Lee

Since Specialization

Citations

This map shows the geographic impact of Chi‐Ming Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Ming Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Ming Lee more than expected).

Fields of papers citing papers by Chi‐Ming Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Ming Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Ming Lee. The network helps show where Chi‐Ming Lee may publish in the future.

Co-authorship network of co-authors of Chi‐Ming Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Ming Lee. A scholar is included among the top collaborators of Chi‐Ming Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Ming Lee. Chi‐Ming Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Quartino, Angelica, Gunilla Huledal, Tjerk Bueters, et al.. (2014). Population pharmacokinetic and pharmacodynamic analysis of plasma Aβ₄₀and Aβ₄₂following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteers. Clinical Pharmacology in Drug Development. 3(5). 396–405. 13 indexed citations

Lin, Yen‐Hung, Aaron Chen, Yen‐Wen Wu, et al.. (2012). Prognostic significance of adipocytokines in systolic heart failure patients. European Journal of Clinical Investigation. 42(10). 1079–1086. 9 indexed citations

Ding, Min, Charles S. Elmore, John R. Zysk, et al.. (2011). [³H]Chiba‐1001(methyl‐SSR180711) has low in vitro binding affinity and poor in vivo selectivity to nicotinic alpha‐7 receptor in rodent brain. Synapse. 66(4). 315–322. 17 indexed citations

Witte, David G., et al.. (1994). Regulation of the Release of Interleukin‐6 from Human Astrocytoma Cells. Journal of Neurochemistry. 63(3). 980–987. 54 indexed citations

Dong, Hui, Jian‐Zhong Sheng, Chi‐Ming Lee, & Tak Ming Wong. (1993). Calcium antagonistic and antiarrhythmic actions of CPU‐23, a substituted tetrahydroisoquinoline. British Journal of Pharmacology. 109(1). 113–119. 48 indexed citations

Dong, Hui, Chi‐Ming Lee, Wenlong Huang, & Sixun Peng. (1992). Cardiovascular effects of substituted tetrahydroisoquinolines in rats. British Journal of Pharmacology. 107(1). 262–268. 27 indexed citations

Lee, Chi‐Ming, et al.. (1991). Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus. British Journal of Pharmacology. 103(3). 1719–1724. 43 indexed citations

Lee, Chi‐Ming. (1985). Potentiation by cholinoceptor agonists of contractions to field stimulation of rat vas deferens. British Journal of Pharmacology. 86(3). 671–676. 12 indexed citations

Lee, Chi‐Ming. (1982). Enzymic Inactivation of Substance P in the Central Nervous System. Novartis Foundation symposium. 165–185. 14 indexed citations

10.

Lee, Chi‐Ming, Bengt Sandberg, Michael R. Hanley, & Leslie L. Iversen. (1981). Purification and Characterisation of a Membrane‐Bound Substance‐P‐Degrading Enzyme from Human Brain. European Journal of Biochemistry. 114(2). 315–327. 139 indexed citations

11.

Sandberg, Bengt, Chi‐Ming Lee, Michael R. Hanley, & Leslie L. Iversen. (1981). Synthesis and Biological Properties of Enzyme‐Resistant Analogues of Substance P. European Journal of Biochemistry. 114(2). 329–337. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact